Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
The Fresh Market, Inc.’s (TFM - Snapshot Report) second quarter adjusted earnings of 28 cents inched past the Zacks Consensus Estimate of 27 cents by a penny. Earnings improved 26.4% from the prior-year quarter. Solid top line and comparable sales growth combined with better margins drove the earnings in the quarter.
The second quarter earnings included impact of 2 cents related to transaction expenses forequity offering (1 cent) and legal settlement costs (1 cent).
Quarter in Detail
Total revenue of this specialty grocery retailer increased 20.6% to $313.0 million, driven by comparable sales growth of 8% and strong new-store productivity level. Comparable store sales benefitted from higher customer trafficand increase in transaction size.
Gross profit expanded 25.6% to $106.7 million in the quarter, while gross margins improved 140 basis points to 34.1% due to expansion of merchandise margins.
Selling, general, and administrative expenses (SG&A), including expenses related to the equity offering and legal settlement, increased 25.8% to $74 million. As a percentage of revenue, SG&A expenses increased 100 basis points to 23.7% due to higher corporate expenses.
Operating margins increased 40 basis points in the quarter to 6.9%, driven by solid gross margins.
Fresh Markets opened five new stores in the quarter. As on July 29, 2012, the company operated 121 stores in 24 states.
Outlook for 2012
Following the strong first half results and an optimistic outlook for the next half, Fresh Market raised its financial guidance for 2012.
Fresh Market expects to generate comparable store sales growth in the range of 5.5% to 6.5% for 2012, up from prior guidance range of 4.5% to 6.5%. Comparable store sales growth is expected to continue to be driven by increasing transactions and transaction size.
Operating margins are expected to increase 30 to 50 basis points over 2011 margin of 7.5%, up from prior expectation of an increase in the range of 20 to 40 basis points. The operating margin guidance includes the impact of equity offering and legal settlement costs incurred in the second quarter.
Earnings are expected to range between $1.33 and $1.38, up from prior guidance range of $1.28 to $1.34. The earnings guidance represents an increase of 25% to 30% over fiscal 2011 earnings per share of $1.07. Fresh Market plans to open 14-16 stores and relocate one store in 2012.
Capital expenditure guidance range of approximately$95 million to $105 million remained unchanged, which mainly deals with real estate investments.
Our Recommendation
We currently have a Neutral recommendation on Fresh Market. The stock carries a Zacks #2 Rank (a short-term ‘Buy’ rating). The back-to-back strong quarterly results and the improved guidance justifythe short-term Buy rating on the stock.
Get the full Snapshot Report on TFM - FREE